Genetics of the ghrelin system

Endocrine Development

Volumn 25, Issue , 2013, Pages 25-40

  Gueorguiev, Maria ^a   Korbonits, Márta ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GHRELIN RECEPTOR; GLUCOSE;

ADDICTION; APPETITE; ARTICLE; BODY HEIGHT; BODY WEIGHT; EATING DISORDER; GENETIC ANALYSIS; GENETIC VARIABILITY; GHSR GENE; GLUCOSE METABOLISM; HUMAN; IMMUNOPATHOLOGY; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84877940165     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000348665     Document Type: Article

References (56)

1. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S: A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198.
2. Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, van der Lely AJ, Deghenghi R, Ghigo E: Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 2001; 86: 5083-5086.
3. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormonereleasing acylated peptide from stomach. Nature 1999; 402: 656-660.
4. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ: Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310: 996-999.
5. Benso A, St-Pierre DH, Prodam F, Gramaglia E, Granata R, van der Lely AJ, Ghigo E, Broglio F: Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. Eur J Endocrinol. 2012; 166: 911-916.
6. Ukkola O, Ravussen E, Jacobson P, et al: Rapid communications: mutations in the ghrelin/preproghrelin gene associated with obesity in humans. J Clin Endocrinol Metab 2001; 86: 3996-3999.
7. Vivenza D, Rapa A, Castellino N, et al: Ghrelin gene polymorphisms and ghrelin, insulin, IGF-1, leptin and anthropometric data in children and adolescents. Eur J Endocrinol 2004; 151: 127-133.
8. Ukkola O, Ravussen E, Jacobson P, et al: Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res 2002; 10: 782-791.
9. Korbonits M, Gueorguiev M, O'Grady E, Lecoeur C, Swan DC, Mein CA, Weill J, Grossman AB, Froguel P: A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab 2002; 87: 4005-4008.
10. Miraglia DG, Santoro N, Cirillo G, et al: Molecular screening of the ghrelin gene in Italian obese children: the Leu72Met variant is associated with an earlier onset of obesity. Int J Obes Relat Metab Disord 2002; 28: 447-450.
11. Hinney A, Hoch A, Geller F, et al: Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J Clin Endocrinol Metab 2002; 87: 2716-2719.
12. Kuzuya M, Ando F, Iguchi A, Shimokata H: Preproghrelin Leu72Met variant contributes to overweight in middle-aged men of a Japanese large cohort. Int J Obes (Lond) 2006; 30: 1609-1614.
13. Leskel P, Ukkola O, Vartiainen J, Rönnemaa T, Kaprio J, Bouchard C, Kesniemi YA: Fasting plasma total ghrelin concentrations in monozygotic twins discordant for obesity. Metabolism 2009; 58: 174-179.
14. Robitaille J, Prusse L, Bouchard C, Vohl MC: Genes, fat intake, and cardiovascular disease risk factors in the Quebec Family Study. Obesity (Silver Spring) 2007; 15: 2336-2347.
15. Tang NP, Wang LS, Yang L, Gu HJ, Zhu HJ, Zhou B, Sun QM, Cong RH, Wang B: Preproghrelin Leu-72Met polymorphism in Chinese subjects with coronary artery disease and controls. Clin Chim Acta 2008; 387: 42-47.
16. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hmlinen H, Ilanne-Parikka P, Keinnen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in life style among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
17. Kilpelinen TO, Lakka TA, Laaksonen DE, Mager U, Salopuro T, Kubaszek A, Todorova B, Laukkanen O, Lindström J, Eriksson JG, Hmlinen H, Aunola S, Ilanne-Parikka P, Keinnen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M, Finnish Diabetes Prevention Study Group: Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study. Metabolism 2008; 57: 428-436.
18. Ando T, Ichimaru Y, Konjiki F, Shoji M, Komaki G: Variations in the preproghrelin gene correlate with higher body mass index, fat mass, and body dissatisfaction in young Japanese women. Am J Clin Nutr 2007; 86: 25-32.
19. Gueorguiev M, Lecoeur C, Meyre D, Benzinou M, Mein CA, Hinney A, Vatin V, Weill J, Heude B, Hebebrand J, Grossman AB, Korbonits M, Froguel P: Association studies on ghrelin and ghrelin receptor gene polymorphisms with obesity. Obesity (Silver Spring) 2009; 17: 745-754.
20. Vartiainen J, Kesaniemi YA, Ukkola O: Sequencing analysis of ghrelin gene 5 ' flanking region: relations between the sequence variants, fasting plasma total ghrelin concentrations, and body mass index. Metabolism 2006; 55: 1420-1425.
21. den Hoed M, Smeets AJ, Veldhorst MA, Nieuwenhuizen AG, Bouwman FG, Heidema AG, Mariman EC, Westerterp-Plantenga MS, Westerterp KR: SNP analyses of postprandial responses in (an)orexigenic hormones and feelings of hunger reveal long-term physiological adaptations to facilitate homeostasis. Int J Obes (Lond) 2008; 32: 1790-1798.
22. Dossus L, McKay JD, Canzian F, et al: Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a casecontrol study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC). Carcinogenesis 2008; 29: 1360-1366.
23. Gjesing AP, Larsen LH, Torekov SS, Hainerov IA, Kapur R, Johansen A, Albrechtsen A, Boj S, Holst B, Harper A, Urhammer SA, Borch-Johnsen K, Pisinger C, Echwald SM, Eiberg H, Astrup A, Lebl J, Ferrer J, Schwartz TW, Hansen T, Pedersen O: Family and population-based studies on variation within the ghrelin receptor locus in relation to measures of obesity. PlosOne 2010; 5:e10084.
24. Mager U, Kolehmainen M, Lindström J, Eriksson JG, Valle TT, Hmlinen H, Ilanne-Parikka P, Keinnen-Kiukaanniemi S, Tuomilehto JO, Pulkkinen L, Uusitupa MI, Finnish Diabetes Prevention Study Group: Association between ghrelin gene variations and blood pressure in subjects with impaired glucose tolerance. Am J Hypertens 2006; 19: 920-926.
25. Matzko ME, Argyropoulos G, Wood GC, Chu X, McCarter RJ, Still CD, Gerhard GS: Association of ghrelin receptor promoter polymorphisms with weight loss following Roux-en-Y gastric bypass surgery. Obes Surg 2012; 22: 783-790.
26. Garcia EA, Heude B, Petry CJ, Gueorguiev M, Hassan-Smith ZK, Spanou A, Ring SM, Dunger DB, Wareham N, Sandhu MS, Ong KK, Korbonits M: Ghrelin receptor gene polymorphisms and body size in children and adults. J Clin Endocrinol Metab. 2008; 93: 4158-4161.
27. Riedl S, Hughes I, Harris M, Leong GM, Beilby J, Sly P, Choong CS: Growth hormone secretagogue receptor (GHSR) gene polymorphishms are associated with stature throughout pregnancy. Eur J Endocrinol 2012; 166: 1079-1085.
28. Wang HJ, Geller F, Dempfle A Schuble N, Friedel S, Lichtner P, Fontenla-Horro F, Wudy S, Hagemann S, Gortner L, Huse K, Remschmidt H, Bettecken T, Meitinger T, Schfer H, Hebebrand J, Hinney A: Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature. J Clin Endocrinol Metab 2004; 89: 157-162.
29. Cellini E, Nacmias B, Brecelj-Anderluh M, et al: Case-control and combined family trios analysis of three polymorphisms in the ghrelin gene in European patients with anorexia and bulimia nervosa. Psychiatr Genet 2006; 16: 51-52.
30. Monteleone P, Tortorella A, Castaldo E, Di Filippo C, Maj M: No association of the Arg51Gln and Leu-72Met polymorphisms of the ghrelin gene with anorexia nervosa or bulimia nervosa. Neurosci Lett 2006; 398: 325-327.
31. Kindler J, Bailer U, de Zwaan M, Fuchs K, Leisch F, Grn B, Strnad A, Stojanovic M, Windisch J, Lennkh-Wolfsberg C, El-Giamal N, Sieghart W, Kasper S, Aschauer H: No association of the neuropeptide Y (Leu7Pro) and ghrelin gene (Arg51Gln, Leu72Met, Gln90Leu) single nucleotide polymorphisms with eating disorders. Nord J Psychiatry 2011; 65: 203-207.
32. Steinle NI, Pollin TI, O'Connell JR, Mitchell BD, Shuldiner AR: Variants in the ghrelin gene are associated with metabolic syndrome in the Old Order Amish. J Clin Endocrinol Metab 2005; 90: 6672-6677.
33. Ando T, Komaki G, Naruo T, et al: Possible role of preproghrelin gene polymorphisms in susceptibility to bulimia nervosa. Am J Med Genet B Neuropsychiatr Genet 2006; 141B:929-934.
34. Miyasaka K, Hosoya H, Sekime A, Ohta M, Amono H, Matsushita S, Suzuki K, Higuchi S, Funakoshi A: Association of ghrelin receptor gene polymorphism with Bulimia nervosa in a Japanese population. J Neural Transm 2006; 113: 1279-1285.
35. Dardennes RM, Zizzari P, TolleV, Foulon C, Kipman A, Romo L, Iancu-Gontard D, Boni C, Sinet PM, Thrse Bluet M, Estour B, Mouren MC, Guelfi JD, Rouillon F, Gorwood P, Epelbaum J: Famiy trios analysis of common polymorphisms in the obestatin/ ghrelin, BDNF and AGRP genes in patients with anorexia nervosa: association with subtype, body mass index, severity and age of onset. Psychoneuroendocrinology 2007; 32: 106-113.
36. Mller TD, Tschöp MH, Jarick I, Ehrlich S, Scherag S, Herpertz-Dahlmann B, Zipfel S, Herzog W, de Zwaan M, Burghardt R, Fleischhaker C, Klampfl K, Wewetzer C, Herpertz S, Zeeck A, Tagay S, Burgmer M, Pfluger PT, Scherag A, Hebebrand J, Hinney A: Genetic variation of the ghrelin activator gene ghrelin O-acyltransferase (GOAT) is associated with anorexia nervosa. J Psychiatr Res 2011; 45: 706-711.
37. Mager U, Lindi V, Lindstrom J Eriksson JG, Valle TT, Hmlinen H, Ilanne-Parikka P, Keinnen-Kiukaanniemi S, Tuomilehto J, Laakso M, Pulkkinen L, Uusi tupa M, Finnish Diabetes Prevention Study Group: Ass ociation of the Leu72Met polymorphism of the ghrelin gene with the risk of type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study. Diabet Med 2006; 23: 685-689.
38. Zavarella S, Petrone A, Zampetti S, Gueorguiev M, Spoletini M, Mein CA, Leto G, Korbonits M, Buzzetti R: A new variation in the promoter region, the -604C>T, and the Leu72Met polymorphism of the ghrelin gene are associated with protection to insulin resistance. Int J Obes 2008; 32: 663-668.
39. Berthold HK, Giannakidou E, Krone W, Mantzoros CS, Gouni-Berthold I: The Leu72Met polymorphism of the ghrelin gene is associated with decreased risk for type 2 diabetes. Clin Chim Acta 2009; 399: 112-116.
40. Liao N, Xie ZK, Huang J, Xie ZF: Association between the ghrelin Leu72Met polymorphism and type 2 diabetes risk: a meta-analysis. Gene 2013;pii: S0378-1119(12)01653-8.
41. Garcia EA, King P, Sidhu K, Ohgusu H, Walley A, Lecoeur C, Gueorguiev M, Khalaf S, Davies D, Grossman AB, Kojima M, Petersenn S, Froguel P, Korbonits M: The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes. Eur J Endocrinol 2009; 161: 307-315.
42. Poykko S, Ukkola O, Kauma H, Savolainen MJ, Kesaniemi YA: Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects. Diabetologia 2003; 46: 455-458.
43. Choi HJ, Cho YM, Moon MK, Choi HH, Shin HD, Jang HC, Kim SY, Lee HK, Park KS: Polymorphisms in the ghrelin gene are associated with serum highdensity lipoprotein cholesterol level and not with type 2 diabetes mellitus in Koreans. J Clin Endocrinol Metab 2006; 91: 4657-4663.
44. Dos Santos ICR, Frigeri HR, Daga DR: The ghrelin gene allele 51Q (rs34911341) is a protective factor against the development of gestational diabetes. Clin Chim Acta 2010; 411: 886-887.
45. Vartiainen J, Poykko SM, Raisanen T, Kesaniemi YA, Ukkola O: Sequencing analysis of the ghrelin receptor (growth hormone secretagogue receptor type 1a) gene. Eur J Endocrinol 2004; 150: 457-463.
46. Mager U, Degenhardt T, Pulkkinen L, Kolehmainen M, Tolppanen AM, Lindstrom J, Eriksson JG, Carlberg C, Tuomilehto J, Uusitupa M, Finnish Diabetes Prevention Study Group: Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance. PLoSOne 2008; 3:e2941.
47. Zou CC, Huang K, Liang L, Zhao ZY: Polymorphisms of the ghrelin/obestatin gene and ghrelin levels in Chinese children with short stature. Clin Endocrinol (Oxf) 2008; 69: 99-104.
48. Gueorguiev M, Lecoeur C, Benzinou M, Mein CA, Meyre D, Vatin V, Weill J, Heude B, Grossman AB, Froguel P, Korbonits M: A genetic study of the ghrelin and growth hormone secretagogue receptor (GHSR) genes and stature. Ann Hum Genet 2009; 73: 1-9.
49. Gueorguiev M, Wiltshire S, Garcia EA, Mein C, Lecoeur C, Kristen B, Allotey R, Hattersley AT, Walker M, O'rahilly S, Froguel P, Grossman AB, Mc-Carthy MI, Hitman GA, Korbonits M: Examining the candidacy of ghrelin as a gene responsible for variation in adult stature in a United Kingdom population with type 2 diabetes. J Clin Endocrinol Metab 2007; 92: 2201-2204.
50. Garcia EA, Heude B, Petry CJ, Gueorguiev M, Hassan-Smith ZK, Spanou A, Ring SM, Dunger DB, Wareham N, Sandhu MS, Ong KK, Korbonits M: Ghrelin receptor gene polymorphisms and body size in children and adults. J Clin Endocrinol Metab 2008; 93: 4158-4161.
51. Lango Allen H, Estrada K, Lettre G, et al: Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010; 467: 832-838.
52. Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton MP, Grouselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y, Amselem S: Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 2006; 116: 760-768.
53. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, Barrett JH, König IR, Stevens SE, Szymczak S, Tregouet DA, Iles MM, Pahlke F, Pollard H, Lieb W, Cambien F, Fischer M, Ouwehand W, Blankenberg S, Balmforth AJ, Baessler A, Ball SG, Strom TM, Braenne I, Gieger C, Deloukas P, Tobin MD, Ziegler A, Thompson JR, Schunkert H, WTCCC and the Cardiogenics Consortium: Genomewide association analysis of coronary artery disease. N Engl J Med 2007; 357: 443-453.
54. Pantel J, Legendre M, Nivot S, Morisset S, Vie-Luton MP, Le Bouc Y, Epelbaum J, Amselem S: Recessive isolated growth hormone deficiency and mutations in the ghrelin receptor. J Clin Endocrinol Metab 2009; 94: 4334-4341.
55. Inoue H, Kangawa N, Kinouchi A, Sakamoto Y, Kimura C, Horikawa R, Shigematsu Y, Itakura M, Ogata T, Fujieda K, Japan Growth Genome Consortium: Identification and functional analysis of novel human growth hormone secretagogue receptor (GHSR) gene mutations in Japanese subjects with short stature. J Clin Endocrinol Metab 2011; 96:E373-E378.
56. Pugliese-Pires PN, Fortin JP, Arthur T, Latronico AC, Mendonca BB, Villares SM, Arnhold IJ, Kopin AS, Jorge AA: Novel inactivating mutations in the GH secretagogue receptor gene in patients with constitutional delay of growth and puberty. Eur J Endocrinol 2011; 165: 233-241.